Company news
Oxford BioDynamics PLC news in 2019
Oxford BioDynamics PLC's news releases, calls and decks from 2019, newest first.
OBD enters into master service agreement
December 20, 2019
Prelim Results for year ended 30 September 2019
December 10, 2019
OBD's EpiSwitch featured in presentations
November 8, 2019
OBD appoints Iain McInnes to Advisory Board
October 30, 2019
First patient enrolled in ALS biomarker study
October 25, 2019
OBD to present at MAC10
July 19, 2019
OBD appoints Dr Bartu Ahiska
June 13, 2019
Board Transition
May 31, 2019
Interim Results for 6 months ended 31 March 2019
May 28, 2019
OBD to present at China BIO Conference
May 8, 2019
OBD joins ALS Biomarker study sponsored by MTPA
May 3, 2019
Notice of Interim Results
April 29, 2019
Queen's Award for Enterprise
April 23, 2019
Board Appointments
April 5, 2019
OBD US subsidiary and commercial lead
April 2, 2019
OBD joins Imperial in a prostate cancer trial
March 19, 2019